A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis
Clinical trial NCT05235269 · COMPLETED
Trial details
- NCT number
- NCT05235269
- Sponsor
- Attralus, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2023-02-06
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.